---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-042203"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2023-11-21T23:59:59+00:00"
generated_at: "2026-06-07T22:31:23.462156+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix regains Nasdaq compliance by meeting $2.5M equity minimum

## Summary
- Received Nasdaq confirmation on Nov 20, 2023 that it meets minimum stockholders' equity of $2.5M.
- Previously disclosed deficiency on May 23, 2023 with equity of ~$2.2M; now resolved.
- Listing matter closed; no further action required per Nasdaq Staff.

## SEC filing metadata
- accession: 0001493152-23-042203
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2023-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315223042203/0001493152-23-042203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315223042203/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-042203
- JSON: https://secwatch.observer/filing/0001493152-23-042203.json
- Plain text: https://secwatch.observer/filing/0001493152-23-042203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.